148 related articles for article (PubMed ID: 27651323)
41. Erdosteine for COPD exacerbations.
Drug Ther Bull; 2008 Oct; 46(10):79-80. PubMed ID: 18832259
[TBL] [Abstract][Full Text] [Related]
42. Study of body composition, lung function, and quality of life following use of anabolic steroids in patients with chronic obstructive pulmonary disease.
Daga MK; Khan NA; Malhotra V; Kumar S; Mawari G; Hira HS
Nutr Clin Pract; 2014 Apr; 29(2):238-45. PubMed ID: 24552826
[TBL] [Abstract][Full Text] [Related]
43. Exercise-induced systemic effects in muscle-wasted patients with COPD.
Van Helvoort HA; Heijdra YF; Thijs HM; Viña J; Wanten GJ; Dekhuijzen PN
Med Sci Sports Exerc; 2006 Sep; 38(9):1543-52. PubMed ID: 16960513
[TBL] [Abstract][Full Text] [Related]
44. Oral
Hirai DM; Jones JH; Zelt JT; da Silva ML; Bentley RF; Edgett BA; Gurd BJ; Tschakovsky ME; O'Donnell DE; Neder JA
J Appl Physiol (1985); 2017 May; 122(5):1351-1361. PubMed ID: 28255088
[TBL] [Abstract][Full Text] [Related]
45. Does oxidative stress alter quadriceps endurance in chronic obstructive pulmonary disease?
Koechlin C; Couillard A; Simar D; Cristol JP; Bellet H; Hayot M; Prefaut C
Am J Respir Crit Care Med; 2004 May; 169(9):1022-7. PubMed ID: 15001462
[TBL] [Abstract][Full Text] [Related]
46. Oxidation pathway and exacerbations in COPD: the role of NAC.
Matera MG; Calzetta L; Cazzola M
Expert Rev Respir Med; 2016; 10(1):89-97. PubMed ID: 26567752
[TBL] [Abstract][Full Text] [Related]
47. Curcuma longa extract reduces inflammatory and oxidative stress biomarkers in osteoarthritis of knee: a four-month, double-blind, randomized, placebo-controlled trial.
Srivastava S; Saksena AK; Khattri S; Kumar S; Dagur RS
Inflammopharmacology; 2016 Dec; 24(6):377-388. PubMed ID: 27761693
[TBL] [Abstract][Full Text] [Related]
48. An overview of erdosteine antioxidant activity in experimental research.
Moretti M; Marchioni CF
Pharmacol Res; 2007 Apr; 55(4):249-54. PubMed ID: 17267240
[TBL] [Abstract][Full Text] [Related]
49. Effects of erdosteine on smoking-induced lipid peroxidation in healthy smokers.
Basyigit I; Yildiz F; Cekmen M; Duman C; Bulut O
Drugs R D; 2005; 6(2):83-9. PubMed ID: 15777101
[TBL] [Abstract][Full Text] [Related]
50. Is there an optimal level of positive expiratory pressure (PEP) to improve walking tolerance in patients with severe COPD?
Russo D; Simonelli C; Paneroni M; Saleri M; Piroddi IM; Cardinale F; Vitacca M; Nicolini A
Arch Bronconeumol; 2016 Jul; 52(7):354-60. PubMed ID: 27085886
[TBL] [Abstract][Full Text] [Related]
51. The effect of erdosteine on airway defence mechanisms and inflammatory cytokines in the settings of allergic inflammation.
Fraňová S; Kazimierová I; Pappová L; Molitorisová M; Jošková M; Šutovská M
Pulm Pharmacol Ther; 2019 Feb; 54():60-67. PubMed ID: 30502381
[TBL] [Abstract][Full Text] [Related]
52. Improvements in symptom-limited exercise performance over 8 h with once-daily tiotropium in patients with COPD.
Maltais F; Hamilton A; Marciniuk D; Hernandez P; Sciurba FC; Richter K; Kesten S; O'Donnell D
Chest; 2005 Sep; 128(3):1168-78. PubMed ID: 16162703
[TBL] [Abstract][Full Text] [Related]
53. Chronic obstructive pulmonary disease in patients undergoing transcatheter aortic valve implantation: insights on clinical outcomes, prognostic markers, and functional status changes.
Mok M; Nombela-Franco L; Dumont E; Urena M; DeLarochellière R; Doyle D; Villeneuve J; Côté M; Ribeiro HB; Allende R; Laflamme J; DeLarochellière H; Laflamme L; Amat-Santos I; Pibarot P; Maltais F; Rodés-Cabau J
JACC Cardiovasc Interv; 2013 Oct; 6(10):1072-84. PubMed ID: 24156967
[TBL] [Abstract][Full Text] [Related]
54. Evaluation of Oxidative Stress and Antioxidant Status in Chronic Obstructive Pulmonary Disease.
Singh S; Verma SK; Kumar S; Ahmad MK; Nischal A; Singh SK; Dixit RK
Scand J Immunol; 2017 Feb; 85(2):130-137. PubMed ID: 28256060
[TBL] [Abstract][Full Text] [Related]
55. Erdosteine improves oxidative damage in a rat model of renal ischemia-reperfusion injury.
Gurel A; Armutcu F; Cihan A; Numanoglu KV; Unalacak M
Eur Surg Res; 2004; 36(4):206-9. PubMed ID: 15263825
[TBL] [Abstract][Full Text] [Related]
56. Evaluation of efficacy and safety of erdosteine in patients affected by chronic bronchitis during an infective exacerbation phase and receiving amoxycillin as basic treatment (ECOBES, European Chronic Obstructive Bronchitis Erdosteine Study).
Marchioni CF; Polu JM; Taytard A; Hanard T; Noseda G; Mancini C
Int J Clin Pharmacol Ther; 1995 Nov; 33(11):612-8. PubMed ID: 8688986
[TBL] [Abstract][Full Text] [Related]
57. Dynamic hyperinflation, arterial blood oxygen, and airway oxidative stress in stable patients with COPD.
García-Rio F; Romero D; Lores V; Casitas R; Hernanz A; Galera R; Alvarez-Sala R; Torres I
Chest; 2011 Oct; 140(4):961-969. PubMed ID: 21436248
[TBL] [Abstract][Full Text] [Related]
58. Clinical effects of erdosteine in the treatment of acute respiratory tract diseases in children.
Balli F; Bergamini B; Calistru P; Ciofu EP; Domenici R; Doros G; Dragomir D; Gherghina I; Iordachescu F; Murgoci G; Orasanu D; Plesca D; Vaccaro A; Assereto R
Int J Clin Pharmacol Ther; 2007 Jan; 45(1):16-22. PubMed ID: 17256446
[TBL] [Abstract][Full Text] [Related]
59. A prospective, randomized study: Evaluation of the effect of rosuvastatin in patients with chronic obstructive pulmonary disease and pulmonary hypertension.
Chogtu B; Kuriachan S; Magazine R; Shetty KR; Kamath A; George MM; Tripathy A; Kumar DM
Indian J Pharmacol; 2016; 48(5):503-508. PubMed ID: 27721534
[TBL] [Abstract][Full Text] [Related]
60. Therapeutic use of heparin and derivatives beyond anticoagulation in patients with bronchial asthma or COPD.
Shute JK; Puxeddu E; Calzetta L
Curr Opin Pharmacol; 2018 Jun; 40():39-45. PubMed ID: 29455115
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
